Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)
China · Delayed Price · Currency is CNY 5.07
-0.07 (-1.36%)
Jul 30, 2026, 3:00 PM CST
SHA:603168 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,897 | 2,754 | 2,519 | 5,085 | 3,397 | 3,058 | |
Market Cap Growth | -38.99% | 9.32% | -50.46% | 49.66% | 11.09% | 20.92% |
Enterprise Value | 2,043 | 2,836 | 2,554 | 4,848 | 3,229 | 2,809 |
Last Close Price | 5.07 | 7.36 | 6.70 | 13.37 | 9.06 | 9.41 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 200.12 | 75.92 | 85.77 |
Forward PE | - | 39.75 | 39.75 | 39.75 | 39.75 | 39.75 |
PS Ratio | 4.13 | 5.95 | 5.20 | 7.88 | 6.18 | 4.86 |
PB Ratio | 1.43 | 2.04 | 1.58 | 2.94 | 1.98 | 2.26 |
P/TBV Ratio | 1.82 | 2.58 | 2.28 | 4.24 | 2.79 | 3.60 |
P/OCF Ratio | 71.60 | 61.29 | 98.11 | 122.54 | 29.36 | 30.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.44 | 6.13 | 5.28 | 7.52 | 5.88 | 4.46 |
EV/EBITDA Ratio | 49.06 | 87.61 | 413.22 | 56.90 | 32.96 | 28.93 |
EV/EBIT Ratio | - | - | - | 234.10 | 81.49 | 67.52 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.20 | 0.22 | 0.16 | 0.10 | 0.02 | 0.03 |
Debt / EBITDA Ratio | 6.41 | 7.78 | 17.10 | 1.87 | 0.38 | 0.36 |
Net Debt / Equity Ratio | 0.11 | 0.06 | 0.04 | -0.11 | -0.30 | -0.15 |
Net Debt / EBITDA Ratio | 4.13 | 2.37 | 10.47 | -2.27 | -5.25 | -2.12 |
Net Debt / FCF Ratio | -1.80 | -1.55 | -0.63 | 1.09 | 15.61 | 3.91 |
Asset Turnover | 0.24 | 0.23 | 0.23 | 0.31 | 0.31 | 0.39 |
Inventory Turnover | 2.91 | 3.49 | 3.14 | 4.02 | 3.90 | 3.96 |
Quick Ratio | 0.54 | 0.70 | 0.72 | 1.17 | 3.10 | 1.54 |
Current Ratio | 0.89 | 0.94 | 0.97 | 1.50 | 3.54 | 2.84 |
Return on Equity (ROE) | -18.72% | -16.23% | -7.32% | 1.46% | 2.92% | 2.68% |
Return on Assets (ROA) | -0.94% | -1.00% | -1.69% | 0.63% | 1.40% | 1.60% |
Return on Invested Capital (ROIC) | -2.01% | -2.07% | -3.62% | 1.15% | 2.80% | 3.04% |
Return on Capital Employed (ROCE) | -2.00% | -2.20% | -3.30% | 1.10% | 2.30% | 3.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -14.43% | -8.67% | -4.90% | 0.50% | 1.32% | 1.17% |
FCF Yield | -4.26% | -1.79% | -4.07% | -3.51% | -0.97% | -1.72% |
Dividend Yield | - | - | - | 0.16% | 0.41% | - |
Payout Ratio | - | - | - | 63.96% | - | - |
Buyback Yield / Dilution | 5.89% | 0.42% | -3.06% | -13.55% | 1.39% | -1.20% |
Total Shareholder Return | 5.89% | 0.42% | -3.06% | -13.39% | 1.80% | -1.20% |